Archives for January 2014

Editorial Note: The marketing of pharmaceuticals avails of something given to no other area of marketing - the product is made available on prescription-only. In this post Johanna Ryan, from RxISK's Community Advisory Board, spells out the risks this gives rise to. This is a theme that has come up often and one we will return to. Direct to consumers? If you live in the USA, I … [Read more...] about The Devil’s Disclaimer

Editorial note: We follow up the Guilty post last week with a piece written by Peter Gøtzsche that has caused a stir in Denmark and provoked some of the Danish professors he critiques to respond. At the Nordic Cochrane Centre, we have researched antidepressants for several years and I have long wondered why leading professors of psychiatry base their practice on a number … [Read more...] about Psychiatry Gone Astray

Days of reckoning? A little over a year ago, there was consternation in psychiatric circles as a French psychiatrist, Daniele Canarelli was found guilty after her patient hacked a man to death. She had not recogized the hazard he posed. Doctors didn't like the implications they saw. In a series of lectures I have raised the question as to how long it might be before a … [Read more...] about Guilty

Editorial Note: In an End of Year post on RxISK, the concept of a Drug Traffic Accident was introduced. This can refer to being run over by a drug, sometimes called side effects, or adverse events, or adverse drug reactions or it can refer to the trafficking of drugs. This post covers both types. The first part is written by David Antonuccio and the second by the Editorial … [Read more...] about Drug Traffic Accidents: ADHD